Amedica Corporation announced that esteemed financial executive Jay M. Moyes has been elected to its Board of Directors. Mr. Moyes brings more than 30 years of management and leadership experience to the Amedica Board of Directors. He has been instrumental in the financial development and expansion of some of the medical industry's most groundbreaking companies including Myriad Genetics, where he guided the company through its initial public offering.

Mr. Moyes currently sits on the Board of Directors with multiple biotechnology companies including Osiris Therapeutics Inc., Biocardia Inc., Integrated Diagnostics Inc., and Puma Biotechnology Inc. He formerly held a Board position with the Utah Life Science Industry Association.